Detalles de la búsqueda
1.
Integration of Universal Germline Genetic Testing for All New Breast Cancer Patients.
Ann Surg Oncol
; 30(2): 1017-1025, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36161375
2.
Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast Cancer.
Ann Surg Oncol
; 29(5): 2882-2894, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35000083
3.
Identification of putative actionable alterations in clinically relevant genes in breast cancer.
Br J Cancer
; 125(9): 1270-1284, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34455425
4.
Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded population.
Breast Cancer Res Treat
; 189(3): 689-699, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34414532
5.
A Pilot Study for the Feasibility of Exome-Sequencing in Circulating Tumor Cells Versus Single Metastatic Biopsies in Breast Cancer.
Int J Mol Sci
; 21(14)2020 Jul 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32650480
6.
Effects of high-intensity interval training on vascular endothelial function and vascular wall thickness in breast cancer patients receiving anthracycline-based chemotherapy: a randomized pilot study.
Breast Cancer Res Treat
; 177(2): 477-485, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31236810
7.
ASO Visual Abstract: Integration of Universal Germline Genetic Testing for All New Breast Cancer Patients.
Ann Surg Oncol
; 30(2): 1028, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36319870
8.
Correction to: Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded population.
Breast Cancer Res Treat
; 191(1): 223-224, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34625861
9.
Correction to: Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast Cancer.
Ann Surg Oncol
; 29(5): 3064, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35258770
10.
Integrated Proteogenomic Analysis Reveals Distinct Potentially Actionable Therapeutic Vulnerabilities in Triple-Negative Breast Cancer Subtypes.
Cancers (Basel)
; 16(3)2024 Jan 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38339267
11.
Incidence and Mitigation of Corneal Pseudomicrocysts Induced by Antibody-Drug Conjugates (ADCs).
Curr Ophthalmol Rep
; 12(2): 13-22, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38756824
12.
Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery.
Clin Cancer Res
; 30(4): 729-740, 2024 02 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38109213
13.
Breast cancer and neurotransmitters: emerging insights on mechanisms and therapeutic directions.
Oncogene
; 42(9): 627-637, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36650218
14.
Disease characterization in liquid biopsy from HER2-mutated, non-amplified metastatic breast cancer patients treated with neratinib.
NPJ Breast Cancer
; 8(1): 22, 2022 Feb 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-35181666
15.
Factors associated with relapse-free survival after neoadjuvant chemotherapy for breast cancer at a safety net medical center.
Am J Surg
; 223(3): 539-542, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34801227
16.
Multianalyte liquid biopsy to aid the diagnostic workup of breast cancer.
NPJ Breast Cancer
; 8(1): 112, 2022 Sep 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36167819
17.
The Phase II MutHER Study of Neratinib Alone and in Combination with Fulvestrant in HER2-Mutated, Non-amplified Metastatic Breast Cancer.
Clin Cancer Res
; 28(7): 1258-1267, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35046057
18.
Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial.
J Clin Oncol
; 40(28): 3246-3256, 2022 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35584336
19.
Association of Residual Ductal Carcinoma In Situ With Breast Cancer Recurrence in the Neoadjuvant I-SPY2 Trial.
JAMA Surg
; 157(11): 1034-1041, 2022 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36069821
20.
Isolation of circulating epithelial and tumor progenitor cells with an invasive phenotype from breast cancer patients.
Int J Cancer
; 126(3): 669-83, 2010 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19662651